DNM1L and amyotrophic lateral sclerosis: Interestingly, this growth-restoring effect was not observed in Mdivi-1 treatments, suggesting that retardation of axonal growth was not entirely dependent on Drp1 activation and that PP1 may have additional targets for the progression of ALS-related axonal degeneration/growth retardation.